BRC Therapeutics is a startup based in the United States.
BRC Therapeutics is a company headquartered in the United States.
BRC Therapeutics develops prescription medicines based on cannabinoids to address pain and neurological and inflammatory conditions, currently running clinical trials for Complex Regional Pain Syndrome and Aromatase Inhibitor-Induced Arthralgia.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.